Najiba Fekih-Mrissa Selected Research

Najiba Fekih-Mrissa Research Topics

Disease

5	Thrombosis (Thrombus) 01/2020 - 02/2011
5	Alzheimer Disease (Alzheimer's Disease) 09/2017 - 09/2013
4	Protein C Deficiency 04/2013 - 01/2011
3	Retinal Vein Occlusion 09/2017 - 04/2014
3	Thrombophilia 10/2012 - 01/2011
2	Stroke (Strokes) 09/2017 - 04/2014
2	Type 2 Diabetes Mellitus (MODY) 08/2017 - 01/2017
2	Autoimmune Diseases (Autoimmune Disease) 01/2017 - 06/2014
2	Schizophrenia (Dementia Praecox) 01/2017 - 11/2014
2	Venous Thrombosis (Deep-Vein Thrombosis) 09/2015 - 03/2013
2	Hyperhomocysteinemia 05/2013 - 04/2013
2	Pre-Eclampsia (Preeclampsia) 04/2013 - 07/2011
2	Myocardial Infarction 03/2013 - 01/2013
2	Abruptio Placentae (Placental Abruption) 07/2011 - 01/2011
1	Multiple Myeloma 01/2020
1	Disseminated Intravascular Coagulation 01/2020
1	Adenocarcinoma 01/2020
1	Septic Shock (Toxic Shock Syndrome) 01/2020
1	Meningoencephalitis 01/2020
1	Hematoma 01/2020
1	Graves Disease (Basedow Disease) 01/2017
1	Dementia (Dementias) 01/2017
1	Pathologic Constriction (Stenosis) 04/2016
1	hereditary Thrombophilia 09/2015
1	Epiretinal Membrane (Epiretinal Membranes) 09/2015
1	Ischemia 09/2015
1	Immune System Diseases (Immune Disorders) 04/2015
1	Mental Disorders (Mental Disorder) 01/2015
1	Glioma (Gliomas) 01/2015
1	Seizures (Absence Seizure) 01/2015
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 01/2015
1	Drug Resistant Epilepsy 01/2015
1	Vascular Diseases (Vascular Disease) 07/2014
1	Guillain-Barre Syndrome 06/2014
1	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 12/2013
1	Ischemic Stroke 05/2013
1	Myasthenia Gravis 01/2013
1	Venous Thromboembolism 10/2012
1	Chronic Kidney Failure (Chronic Renal Failure) 07/2012
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 07/2011
1	Pregnancy Complications 07/2011

Drug/Important Bio-Agent (IBA)

8	factor V LeidenIBA 04/2016 - 01/2011
7	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 08/2017 - 02/2011
6	Prothrombin (Factor II)IBA 01/2020 - 02/2011
5	HLA-DR Antigens (HLA-DR)IBA 04/2015 - 01/2013
4	HLA Antigens (Human Leukocyte Antigens)IBA 01/2017 - 06/2014
4	HLA-DRB1 Chains (HLA DRB1)IBA 01/2017 - 01/2013
3	Retinaldehyde (Retinal)IBA 09/2017 - 07/2014
3	HomocysteineIBA 08/2017 - 07/2011
3	Blood Group Antigens (Blood Groups)IBA 04/2013 - 01/2011
2	ApolipoproteinsIBA 09/2017 - 04/2014
2	Apolipoproteins E (ApoE)IBA 09/2017 - 04/2014
1	Fibrinogen (Factor I)FDA Link 01/2020
1	fibrin fragment D (D-dimer)IBA 01/2020
1	Biological ProductsIBA 01/2020
1	Dacarbazine (DIC)FDA LinkGeneric 01/2020
1	Biomarkers (Surrogate Marker)IBA 09/2017
1	Plasminogen Activator Inhibitor 1IBA 09/2017
1	Fumigant 93 (D-D)IBA 01/2017
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2017
1	AntibodiesIBA 01/2015
1	Leucine (L-Leucine)FDA Link 01/2015
1	anti-leucine-rich glioma-inactivated 1 autoantibodyIBA 01/2015
1	Protein SIBA 04/2013
1	Proteins (Proteins, Gene)FDA Link 04/2013
1	Protein CIBA 04/2013
1	Genetic Markers (Genetic Marker)IBA 04/2013
1	AntithrombinsIBA 04/2013
1	Heparin (Liquaemin)FDA LinkGeneric 03/2013
1	AnticoagulantsIBA 07/2012
1	Factor V (Coagulation Factor V)IBA 01/2011

Therapy/Procedure

3	Renal Dialysis (Hemodialysis) 04/2016 - 02/2011
1	Drug Therapy (Chemotherapy) 01/2020
1	Resuscitation 01/2020
1	Kidney Transplantation 07/2012